nach oben

Current Diabetes Reports

Erschienen in:

01.11.2015 | Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

The Detection and Management of Diabetes Distress in People With Type 1 Diabetes

verfasst von: Jackie Sturt, Kathryn Dennick, Mette Due-Christensen, Kate McCarthy

Erschienen in: Current Diabetes Reports | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Diabetes distress (DD) represents a significant clinical burden in which levels of DD are related to both glycated haemoglobin (HbA1c) and some self-management behaviours. DD is related to, but different from, depression. Differences in DD experienced in people with type 1 and type 2 diabetes have been observed. Commonly measured using the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS), rates of elevated DD in research study participants range from 20 to 30 %. Risk factors for elevated DD in type 1 diabetes are longer duration of diabetes, severe hypoglycaemia, younger age and being female. A systematic review of intervention studies assessing DD identified eight randomised controlled trials (RCTs) and nine pre-post design studies. Only three studies targeted DD with the intervention. Intervention types were diabetes self-management education (DSME), psychologically informed self-management and devices. DSME pre-post studies, namely the Dose Adjustment For Normal Eating (DAFNE) programme, produced more consistent improvements in DD and HbA1c at follow-up. Psychologically informed self-management was more heterogeneous, but several RCTs were effective in reducing DD. Group interventions offered the greatest benefits across intervention designs.

Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31(7):764–72. This paper offers perspectives on the depression-DD distinction.PubMedCentralPubMedCrossRef

Esbitt SA, Tanenbaum ML, Gonzalez JS. Disentangling clinical depression from diabetes-specific distress: making sense of the mess we’ve made. 2013. In: Screening for depression and other psychological problems in diabetes [Internet]. London: Springer. Available from: http://shibboleth.ovid.com/secure/?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=psyc10&AN=2012-23566-002. http://sfx.kcl.ac.uk/kings?sid=OVID:psycdb&id=pmid:&id=doi:10.1007%2F978-0-85729-751-8_2&genre=article&atitle=Disentangling+clinical+depression+from+diabetes-specific+distress%3A+Making+sense+of+the+mess+we%27ve+made.&title=&issn=&date=2013&volume=&issue=&spage=27&aulast=Esbitt%2C+Sabrina+A&isbn=978-0-85729-750-1&__char_set=utf8.

Friis AM, Johnson MH, Cutfield RG, Consedine NS. Does kindness matter? Self-compassion buffers the negative impact of diabetes-distress on HbA. Diabet Med: J Br Diabet Assoc. 2015 Apr 2.

Sturt J, Dennick K, Hessler D, Hunter B, Oliver J, Purrsell E, et al. High rates of elevated diabetes distress in research populations: a systematic review and meta-analysis. Diabetes UK Professional Conference; London, UK, 2015.

Lerman-Garber I, Barron-Uribe C, Calzada-Leon R, Mercado-Atri M, Vidal-Tamayo R, Quintana S, et al. Emotional dysfunction associated with diabetes in Mexican adolescents and young adults with type-1 diabetes. Salud Publica Mex. 2003;45(1):13–8.PubMedCrossRef

Martyn-Nemeth P, Quinn L, Hacker E, Park H, Kujath AS. Diabetes distress may adversely affect the eating styles of women with type 1 diabetes. Acta Diabetol. 2014;51(4):683–6.PubMedCentralPubMedCrossRef

Reddy J, Wilhelm K, Campbell L. Putting PAID to diabetes-related distress: the potential utility of the problem areas in diabetes (PAID) scale in patients with diabetes. Psychosomatics. 2013;54(1):44–51.PubMedCrossRef

8.••

Balfe M, Doyle F, Smith D et al. What’s distressing about having type 1 diabetes? A qualitative study of young adults’ perspectives. BMC Endocrine Disorders. 2013 Jul 2013;13(25). First and only qualitative study eliciting the experience of DD in general but also specifically in type 1 diabetes.

Tanenbaum ML, Gonzalez JS. The influence of diabetes on a clinician-rated assessment of depression in adults with type 1 diabetes. Diabet Educ. 2012;38(5):695–704.CrossRef

10.

Sturt J MK, Dennick K, Narasimha M, Sankar S & Kumar S. What characterises diabetes distress and its resolution? A documentary analysis. International Diabetes Nursing. 2015a.

11.•

Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabet Endocrinol. 2015;3(6):450–60. This paper offers perspectives on the depression-DD distinction.CrossRef

12.

Pouwer F, Skinner TC, Pibernik-Okanovic M, Beekman ATF, Cradock S, Szabo S, et al. Serious diabetes-specific emotional problems and depression in a Croatian-Dutch-English survey from the European Depression in Diabetes [EDID] Research Consortium. Diabet Res Clin Pract. 2005;70(2):166–73.CrossRef

13.

Lloyd CE, Pambianco G, Orchard TJ. Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with type 1 diabetes? Diabet Med. 2010;27(2):234–7.PubMedCentralPubMedCrossRef

14.

Ehrmann D, Hermanns N, Kulzer B, Bergis N, Maier B, Haak T. Depression in diabetes: the role of diabetes-related distress on incidence and recovery. Diabetologia. 2013; Conference: 49th Annual Meeting of the European Association for the Study of Diabetes, EASD 2013, Barcelona, Spain. Conference start: 20130923. Conference end: 7. Conference Publication: (var.pagings). 56 (p. S463).

15.

Snoek FJ, Kersch NY, Eldrup E, Harman-Boehm I, Hermanns N, Kokoszka A, et al. Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2012;35(11):2128–32.PubMedCentralPubMedCrossRef

16.

Ehrmann D, Hermanns N, Haak T, Kulzer B. The influence of diabetes-related distress on depression. Diabetes. 2014; Conference: 74th Scientific Sessions of the American Diabetes Association, San Francisco, CA, USA. Conference start: 20140613. Conference end: 7. Conference Publication: (var.pagings). 63 (p. A201).

17.

Gask L, Macdonald W, Bower P. What is the relationship between diabetes and depression? A qualitative meta-synthesis of patient experience of co-morbidity. Chronic Illn. 2011;7(3):239–52.PubMedCrossRef

18.

Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have we been missing something important? Diabetes Care. 2011;34(1):236–9.PubMedCentralPubMedCrossRef

19.

Polonsky W, Anderson B, Lohrer P, Welch G, Jacobson A, Aponte J, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.PubMedCrossRef

20.

Polonsky W, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31.PubMedCrossRef

21.

Joensen LE, Tapager I, Willaing I. Diabetes distress in type 1 diabetes—a new measurement fit for purpose. Diabet Med: J Br Diabet Assoc. 2013;30(9):1132–9.CrossRef

22.

Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas in Diabetes (PAID) questionnaire. Diabet Med. 2003;20(1):69–72.PubMedCrossRef

23.

Markowitz JT, Volkening LK, Butler DA, Antisdel-Lomaglio J, Anderson BJ, Laffel LM. Re-examining a measure of diabetes-related burden in parents of young people with type 1 diabetes: the Problem Areas in Diabetes Survey-Parent Revised version (PAID-PR). Diabet Med. 2012;29(4):526–30.PubMedCentralPubMedCrossRef

24.

Weissberg-Benchell J, Antisdel-Lomaglio J. Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes—teen version. Pediatr Diabetes. 2011;12(4 Pt 1):341–4.PubMedCrossRef

25.

Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23(9):1305–9.PubMedCrossRef

26.

Amsberg S, Wredling R, Lins PE, Adamson U, Johansson UB. The psychometric properties of the Swedish version of the Problem Areas in Diabetes Scale (Swe-PAID-20): scale development. Int J Nurs Stud. 2008;45(9):1319–28.PubMedCrossRef

27.

Fisher L, Polonsky W, Hessler D, Stryker L, Masharani U, Blumer I, et al. A new validated measure of diabetes distress for adults with type 1 diabetes. 74th Scientific Sessions of the American Diabetes Association, San Francisco, CA, USA; 2014.

28.••

Sturt J, Dennick K, Hessler D, Hunter B, Oliver J, Fisher L. Effective interventions for reducing diabetes distress: systematic review and meta-analysis. International Diabetes Nursing. 2015b. The first meta-analysis of effective interventions for managing DD in type 1 and type 2 diabetes.

29.

Jones A, Olsen MZ, Perrild HJ, Willaing I. The psychological impact of living with diabetes: descriptive findings from the DAWN2 study in Denmark. Primary Care Diabetes. 2015 Apr 15.

30.

Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–52.PubMedCentralPubMedCrossRef

31.

McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010;53(1):66–9.PubMedCrossRef

32.

Law GU, Walsh J, Queralt V, Nouwen A. Adolescent and parent diabetes distress in type 1 diabetes: the role of self-efficacy, perceived consequences, family responsibility and adolescent-parent discrepancies. J Psychosom Res. 2013;74(4):334–9.PubMedCrossRef

33.••

Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Thordarson HB, Rokne B. Longitudinal relationship between diabetes-specific emotional distress and follow-up HbA1c concentration in adults with type 1 diabetes. Diabet Med. 2015. The first prospective study of the association between DD and HbA1c in type 1 diabetes.

34.

Peyrot MMJJ, Kruger DF. A biopsychosocial model of glycaemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav. 1999;40(2):141–58.PubMedCrossRef

35.

Weinger K, Jacobson AM. Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Educ Couns. 2001;42(2):123–31.PubMedCrossRef

36.

Zagarins SE, Allen NA, Garb JL, Welch G. Improvement in glycemic control following a diabetes education intervention is associated with change in diabetes distress but not change in depressive symptoms. J Behav Med. 2012;35(3):299–304.PubMedCrossRef

37.

Ali Z, Patel NH. Glycaemic control, emotional attitudes and quality of life in patients living with type 1 diabetes. Diabetic Medicine. 2013; Conference: Diabetes UK Professional Conference 2013, Manchester, UK. Conference start: 20130313. Conference end: 5. Conference Publication: (var.pagings). 30 (pp. 104–105).

38.

Sheils E, Knott J, Cavan D, Shaban C. Fear of hypoglycaemia: is there an association with glycaemic control, hypoglycaemic symptoms and diabetes emotional distress in people with type 1 diabetes? Diabetic Medicine. 2012; Conference: Diabetes UK Professional Conference 2012, Glasgow, UK. Conference start: 20120307. Conference end: 9. Conference Publication: (var.pagings). 29 (p. 157).

39.

Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res. 2014;77(3):174–9.PubMedCrossRef

40.

Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35(12):2472–8.PubMedCentralPubMedCrossRef

41.

Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33(1):23–8.PubMedCentralPubMedCrossRef

42.

Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010;33(5):1034–6.PubMedCentralPubMedCrossRef

43.

Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jaconson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care. 1994;10:1178–85.CrossRef

44.

Goebel-Fabbri AEAB, Fikkan J, Franko DL, Pearson K, Weinger K. Improvement and emergence of insulin restriction in women with type 1 diabetes. Diabetes Care. 2011;34(3):545–50.PubMedCentralPubMedCrossRef

45.

van Bastelaar KM, Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AT, et al. Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in type 1 and type 2 diabetes. Diabet Med. 2010;27(7):798–803.PubMedCrossRef

46.

Pibernik-Okanovic M, Grgurevic M, Begic D, Szabo S, Metelko Z. Interaction of depressive symptoms and diabetes-related distress with glycaemic control in type 2 diabetic patients. Diabet Med. 2008;25(10):1252–4.PubMedCrossRef

47.

Schmitt A, Reimer A, Kulzer B, Haak T, Gahr A, Hermanns N. Negative association between depression and diabetes control only when accompanied by diabetes-specific distress. J Behav Med. 2014;38(3):556–64.PubMedCrossRef

48.

Graue M, Haugstvedt A, Wentzel-Larsen T, Iversen MM, Karlsen B, Rokne B. Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud. 2012;49(2):174–82.PubMedCrossRef

49.

Zoffmann V, Vistisen D, Due-Christensen M. A cross-sectional study of glycaemic control, complications and psychosocial functioning among 18- to 35-year-old adults with type 1 diabetes. Diabet Med. 2014;31(4):493–9.PubMedCrossRef

50.

Byrne M, Newell J, Coffey N, MC OH, Cooke D, Dinneen SF. Predictors of quality of life gains among people with type 1 diabetes participating in the Dose Adjustment for Normal Eating (DAFNE) structured education programme. Diabetes Res Clin Pract. 2012;98(2):243–8.PubMedCrossRef

51.

Ting RZ, Nan H, Mandy WM, Kong AP, Ma RC, Wong RY, et al. Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care. 2011;34(5):1094–6.PubMedCentralPubMedCrossRef

52.

West C, McDowell J. The distress experienced by people with type 2 diabetes. Br J Commun Nurs. 2002;7(12):606–13.CrossRef

53.

Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35(2):259–64.PubMedCentralPubMedCrossRef

54.

Rosenbek Minet LK, Wagner L, Lonvig EM, Hjelmborg J, Henriksen JE. The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a randomised controlled trial. Diabetologia. 2011;54(7):1620–9.PubMedCrossRef

55.

Psychological effects of continuous glucose monitoring in type 1-diabetes. Verhaltenstherapie & Verhaltensmedizin. 2009;30(4):458–69. Psychologische effekte der kontinuierlichen glukosemessung bei typ-1-diabetes.

56.

Due-Christensen M, Zoffmann V, Hommel E, Lau M. Can sharing experiences in groups reduce the burden of living with diabetes, regardless of glycaemic control? Diabet Med. 2012;29(2):251–6.PubMedCrossRef

57.

Fleer J, Tovote KA, Keers JC, Links TP, Sanderman R, Coyne JC, et al. Screening for depression and diabetes-related distress in a diabetes outpatient clinic. Diabet Med. 2013;30(1):88–94.PubMedCrossRef

58.

Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469–77.PubMedCrossRef

59.

Duda-Sobczak A, Zozulinska-Ziolkiewicz D, Pisarczyk-Wiza D, Wierusz-Wysocka B. The assessment of factors related to depressive symptoms in adult patients with type 1 diabetes. Diabetologia. 2014; Conference: 50th Annual Meeting of the European Association for the Study of Diabetes, EASD 2014, Vienna, Austria. Conference start: 20140915. Conference end: 9. Conference Publication: (var.pagings). 57 (1 SUPPL. 1) (pp. S420-S421).

60.

Kibbey KJ, Speight J, Wong JLA, Smith LA, Teede HJ. Diabetes care provision: barriers, enablers and service needs of young adults with type 1 diabetes from a region of social disadvantage. Diabet Med. 2013;30(7):878–84.PubMedCrossRef

61.

Hermanns N, Kulzer B, Gulde C, Eberle H, Pradler E, Patzelt-Bath A, et al. Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study. Diabetes Technol Ther. 2009;11(5):275–81.PubMedCrossRef

62.

Nicolucci A, Kovacs Burns K, Holt R, Comaschi M, Hermanns N, Ishii H, et al. Diabetes attitudes, wishes and needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30(7):767–77.PubMedCrossRef

63.

Luyckx K, Rassart J, Weets I. Illness self-concept in type 1 diabetes: a cross-sectional view on clinical, demographic, and psychosocial correlates. Psychol Health Med. 2015;20(1):77–86.PubMedCrossRef

64.

Brierley S, Johnson B, Young V, Eiser C, Heller S. The importance of measuring diabetes distress in young people with type 1 diabetes. Diabetic Medicine. 2012; Conference: Diabetes UK Professional Conference 2012, Glasgow, UK. Conference start: 20120307. Conference end: 9. Conference Publication: (var.pagings). 29 (p. 159).

65.

Joensen LE, Almdal TP, Willaing I. Type 1 diabetes and living without a partner: psychological and social aspects, self-management behaviour, and glycaemic control. Diabet Res Clin Pract. 2013;101(3):278–85.CrossRef

66.

Association AD. Standards of medical care in diabetes. Diabetes Care. 2015;38(Supplement 1):S1–94.

67.

Hajos T, Pouwer F, Skovlund S, Den Oudsten B, Geelhoed‐Duijvestijn P, Tack C, et al. Psychometric and screening properties of the WHO‐5 well‐being index in adult outpatients with type 1 or type 2 diabetes mellitus. Diabet Med. 2013;30(2):e63–9.PubMedCrossRef

68.

Pouwer F, Beekman AT, Lubach C, Snoek FJ. Nurses’ recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns. 2006;60(2):235–40.PubMedCrossRef

69.

Snoek FJ, Van Der Ven NCW, Lubach CHC, Chatrou M, Ader HJ, Heine RJ, et al. Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study. Patient Educ Couns. 2001;45(2):143–8.PubMedCrossRef

70.

Engel L, Cummins R. Impact of dose adjustment for normal eating in Australia (OzDAFNE) on subjective wellbeing, coping resources and negative affects in adults with type 1 diabetes: a prospective comparison study. Diabet Res Clin Pract. 2011;91(3):271–9.CrossRef

71.

Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care. 2012;35(8):1638–42.PubMedCentralPubMedCrossRef

72.

Keen AJA, Duncan E, McKillop-Smith A, Evans ND, Gold AE. Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits? Diabet Med. 2011;29(5):670–6.CrossRef

73.

McIntyre HD, Knight BA, Harvey DM, Noud MN, Hagger VL, Gilshenan KS. Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia. Med J Aust. 2010;192(11):637–40.PubMed

74.

DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal. 2002;325(7367):746.PubMedCentralCrossRef

75.

Snoek FJ, van der Ven NCW, Twisk JWR, Hogenelst MHE, Tromp-Wever AME, van der Ploeg HM, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med. 2008;25(11):1337–42.PubMed

76.

Amsberg S, Anderbro T, Wredling R, Lisspers J, Lins PE, Adamson U, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—a randomized controlled trial. Patient Educ Couns. 2009;77(1):72–80.PubMedCrossRef

77.

Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns. 2006;64(1–3):78–86.PubMedCrossRef

78.•

Zoffmann V, Vistisen D, Due-Christensen M. Flexible guided self-determination intervention for younger adults with poorly controlled type 1 diabetes, decreased HbA and psychosocial distress in women but not in men: a real-life RCT. Diabetic Medicine. 2015 Jan 19. This study provides information on gender differences in DD.

79.

Esbitt SA, Batchelder AW, Tanenbaum ML, Shreck E, Gonzalez JS. “Knowing that you’re not the only one”: perspectives on group-based cognitive-behavioral therapy for adherence and depression (CBT-AD) in adults with type 1 diabetes. Cognitive and Behavioral Practice. 2014 (0).

80.

Hermanns N, Kulzer B, Ehrmann D, Bergis-Jurgan N, Haak T. The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: results of a randomized trial. Diabetes Res Clin Pract. 2013;102(3):149–57.PubMedCrossRef

81.••

Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, et al. The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care. 2015;38(4):551–60. This study specifically targets diabetes distress in patients with co-morbid subclinical depression. DIAMOS intervention was efficacious, compared to controls, in treating sub-threshold depression and elevated diabetes distress more effectively than education alone. Additionally, it prevented deterioration from sub to major depression.PubMed

82.

Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, et al. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled type 1 diabetes: a randomized controlled trial. Diabet Med. 2011;28(10):1158–67.PubMedCrossRef

83.

Solomon P. Peer support/peer provided services underlying processes, benefits, and critical ingredients. Psychiatr Rehabil J. 2004;27(4):392–401.PubMedCrossRef

84.

Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007;30(3):542–8.PubMedCrossRef

85.

Gonzalez JS, Delahanty LM, Safren SA, Meigs JB, Grant RW. Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008;51(10):1822–5.PubMedCentralPubMedCrossRef

86.••

Hessler D, Fisher L, Glasgow RE, Strycker LA, Dickinson LM, Arean PA, et al. Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care. 2014;37(3):617–24. One of only two prospective studies of the association between DD and HbA1c that has established the nature of the longitudinal relationship between these variables.PubMedCentralPubMedCrossRef

Titel: The Detection and Management of Diabetes Distress in People With Type 1 Diabetes
verfasst von: Jackie Sturt
Kathryn Dennick
Mette Due-Christensen
Kate McCarthy
Publikationsdatum: 01.11.2015
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 11/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0660-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2015

Mind the Gap: Race/Ethnic and Socioeconomic Disparities in Obesity

Sex-Specific Differential in Risk of Diabetes-Related Macrovascular Outcomes

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Sustained-Release Steroids for the Treatment of Diabetic Macular Edema

Is There a Relationship Between Oral Health and Diabetic Neuropathy?